InvestSMART

Sonic Healthcare Limited (ASX: SHL) - Announcements

Current share price for SHL : $21.080 0.3 (1.40%)+

ASX company news and announcements for Sonic Healthcare Limited (SHL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Sonic Healthcare Limited (SHL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Sonic Healthcare Limited (SHL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Sonic Healthcare Limited (SHL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$10,419 Becoming a substantial holder 21 Aug 2026 4:22PM $21.080 $21.080 fallen by 0%
$10,419 Financial and Operational Review - Year Ended 30 June 2026 20 Aug 2026 9:23AM $23.560 $21.080 fallen by 10.53%
$10,419 Media Release - Full Year Results to 30 June 2026 20 Aug 2026 9:22AM $23.560 $21.080 fallen by 10.53%
$10,419 Dividend/Distribution - SHL 20 Aug 2026 9:17AM $23.560 $21.080 fallen by 10.53%
$10,419 Preliminary Final Report FY2026 20 Aug 2026 9:17AM $23.560 $21.080 fallen by 10.53%
$10,419 Change in substantial holding 18 Aug 2026 8:07AM $22.810 $21.080 fallen by 7.58%
$10,419 Release of Securities Subject to Voluntary Escrow 17 Jun 2026 4:08PM $19.815 $21.080 risen by 6.38%
$10,419 Completion of Sale and Leaseback of Brisbane Hub Laboratory 15 Jun 2026 4:22PM $19.940 $21.080 risen by 5.72%
$10,419 Change in substantial holding 13 Apr 2026 6:06PM $19.720 $21.080 risen by 6.90%
$10,419 Notification regarding unquoted securities - SHL 2 Apr 2026 4:34PM $19.980 $21.080 risen by 5.51%
$10,419 Change of Director's Interest Notice 9 Mar 2026 4:44PM $21.970 $21.080 fallen by 4.05%
$10,419 Notification regarding unquoted securities - SHL 4 Mar 2026 4:43PM $23.010 $21.080 fallen by 8.39%
$10,419 CEO Presentation Half Year Results to 31 December 2025 19 Feb 2026 8:50AM $21.240 $21.080 fallen by 0.75%
$10,419 Media Release Half Year Results to 31 December 2025 19 Feb 2026 8:49AM $21.240 $21.080 fallen by 0.75%
$10,419 Dividend/Distribution - SHL 19 Feb 2026 8:44AM $21.240 $21.080 fallen by 0.75%
$10,419 Half Yearly Report and Accounts 19 Feb 2026 8:42AM $21.240 $21.080 fallen by 0.75%
$10,419 Change in substantial holding 23 Jan 2026 6:49PM $23.340 $21.080 fallen by 9.68%
$10,419 Change of Director's Interest Notice 24 Nov 2025 4:34PM $23.540 $21.080 fallen by 10.45%
$10,419 Change of Director's Interest Notice 24 Nov 2025 4:33PM $23.540 $21.080 fallen by 10.45%
$10,419 Notification regarding unquoted securities - SHL 21 Nov 2025 4:23PM $23.090 $21.080 fallen by 8.71%
$10,419 Notification regarding unquoted securities - SHL 21 Nov 2025 4:21PM $23.090 $21.080 fallen by 8.71%
$10,419 Final Director's Interest Notice 21 Nov 2025 4:17PM $23.090 $21.080 fallen by 8.71%
$10,419 Change of Director's Interest Notice 21 Nov 2025 4:16PM $23.090 $21.080 fallen by 8.71%
$10,419 Initial Director's Interest Notice 21 Nov 2025 11:47AM $22.980 $21.080 fallen by 8.27%
$10,419 Notification of cessation of securities - SHL 21 Nov 2025 11:42AM $22.980 $21.080 fallen by 8.27%

1 - 25 of 839 results

Page 1 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.